Prayer as a Possible Adjuvant Treatment for Breast Cancer
NCT ID: NCT00519545
Last Updated: 2012-01-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2006-03-31
2012-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Complementary or Alternative Medicine Practices Used by Women at Increased Risk for Breast Cancer
NCT00020098
Effect of Intercessory Prayer in Patients With Breast Cancer in Radiotherapy Treatment: Clinical Trial
NCT02716467
Partial Breast Radiation Therapy in Treating Women Undergoing Breast-Conserving Therapy for Early Stage Breast Cancer
NCT00527293
Radiation Therapy in Treating Women Who Have Undergone Surgery for Early-Stage Invasive Breast Cancer
NCT00005957
Effects of Yoga in Breast Cancer Patients
NCT00508794
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
scripted prayer group (intervention group)
Prayer
Data collection on physiological biomarkers
2
no prayer intervention group (non-intervention group)
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Prayer
Data collection on physiological biomarkers
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Initial diagnosis of breast cancer within 5 year of study enrollment.
3. Not currently receiving chemotherapy or radiation therapy. Hormone therapy is allowed.
4. Life expectancy of at least 12 months.
5. ECOG performance status of 0, 1, or 2.
6. Willing to sign informed consent indicating that they are aware of the investigational nature of the study and the randomized study design.
7. Willing to comply with monthly follow-up phone calls.
8. Willing to complete questionnaires at regular oncology clinic visits.
9. Able to read write \& understand English.
Exclusion Criteria
2. Less than 3 months since last dose of chemotherapy or radiation therapy.
3. Breast cancer diagnosis more than 5 years prior to study enrollment
4. Less than 21 or greater than to 80 years old.
5. Life threatening or severe concurrent non-malignant conditions.
6. Uncontrolled diabetes mellitus.
7. Severe heart disease.
8. Severe liver disease. Severe lung disease.
9. History of smoking within 5 years of study enrollment.
10. Psychological or psychiatric disorder that would interfere with study compliance.
11. History of missed appointments or poor medical compliance.
12. Inability to understand instructions on how to complete a questionnaire.
13. No access to a phone.
21 Years
80 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gateway for Cancer Research
OTHER
Southwestern Regional Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cancer Control Center of Charleston, Charleston South Carolina
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephen Ray, MD
Role: PRINCIPAL_INVESTIGATOR
Cancer Treatment Centers of America
Petra Ketterl, MD
Role: PRINCIPAL_INVESTIGATOR
Cancer Treatment Centers of America at Southwestern Regional Medical Center
Percy McCray, Rev.
Role: PRINCIPAL_INVESTIGATOR
Cancer Treatment Centers of America
Michael Langham, Rev.
Role: PRINCIPAL_INVESTIGATOR
Cancer Treatment Centers of America at Southwestern Regional Medical Center
Daniel Nixon, MD
Role: PRINCIPAL_INVESTIGATOR
Cancer Control Center of Charleston
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cancer Treatment Centers of America at Southwestern Regional medical Center
Tulsa, Oklahoma, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CTCA 05-04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.